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Free energyToll-like receptors (TLRs) take part in both the innate and adaptive immune systems. The role of the
transmembrane domain in TLR signaling is still elusive, while its importance for the TLR activation
was clearly demonstrated. In the present study the ability of the TLR3 transmembrane domain to
form dimers and trimers in detergent micelles was shown by solution NMR spectroscopy. Spatial
structures and free energy magnitudes were determined for the TLR3 transmembrane domain in
dimeric and trimeric states, and two possible surfaces that may be used for the helix–helix interac-
tion by the full-length TLR3 were revealed.
Structured summary of protein interactions:
TLR3-TM and TLR3-TM bind by nuclear magnetic resonance (1, 2)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction There is a lot of data available on the structural and biologicalToll-like receptors (TLRs) are one of the key players in both the
innate and adaptive immune systems [1]. These proteins recognize
pathogen-associated molecular patterns (PAMP), such as compo-
nents of bacterial cell walls (human TLRs 1, 2, 4, 5, 6, 10) or viral
nucleic acids (human TLRs 3, 7, 8, 9) and induce the release of
the effector molecules of the immune system [2]. TLRs belong to
the type I transmembrane proteins and consist of the extracellular
ligand-binding domain extracellular domain (ECD), single trans-
membrane a-helix and intracellular Toll-interleukin I receptor
domain (TIR), which is responsible for the downstream signaling
[1,2]. According to crystal structures, TLRs form homo- or heterodi-
meric signaling complexes interacting with the single PAMP
molecule [3–7]. The medical and biological signiﬁcance of toll-like
receptor (TLR) signaling is obvious, since the disregulation of the
TLR system may cause various autoimmune diseases and septic
shock [8–11], and some therapeutic strategies targeting TLRs have
already emerged [8,11,12].aspects of the TLR signaling, mainly related to the roles of the
(ECD) and TIR in the process. Moreover, a computer model of the
dimeric full-length TLR3 receptor in the active state was build
[4]. Nevertheless, the role of the transmembrane domain (TMD)
in TLR signaling is still elusive, while its signiﬁcance for the TLR
activation was demonstrated in recent studies. In particular, it
was shown that constitutively dimerizing ECDs can cause the
ligand-independent activation of the receptor by bringing together
isolated transmembrane domain (TMD) and TIR domains [13,14].
The TLR9 receptor was shown to exist as preformed dimers in
the cell membrane, while ligand binding induces only the rear-
rangement of the subunits [15], which seems similar to the ‘‘cou-
pled rotation’’ activation mechanism, implying the crucial role of
the receptor TMD, proposed for some receptor tyrosine kinases
[16]. And, last, it was demonstrated that decoupling of the ECD
and TIR of TLR4 from the TMD can disrupt its signaling [17] and
that TLR4 constructs with the deleted ECD are constitutively active
and dimeric [18]. Isolated TMDs of all TLR receptors were shown to
homodimerize in bacterial membranes, with TMDs of TLR2,3,8,9
having the highest propensity to perform homotypic interactions
[19]. Taking into account all aforesaid, it is obvious that the struc-
tural investigations of TLR TMD dimers is necessary, because these
domains can as well serve as targets for emerging therapies. In the
present work the NMR study of homotypic interactions of TLR3
TMD is reported.
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2.1. Construction of expression plasmid
The gene encoding transmembrane and juxtamembrane
residues 698–730 (MD698SAPFELFFMINTSILLIFIFIVLLIHFEGWRI,
TLR3-TM) of human TLR3 was ampliﬁed by PCR from four
chemically synthesized oligonucleotides (Evrogen, Russia) partially
overlapped along their sequences. The PCR products were cloned
into pET22b vector using ligation by NdeI and HindIII restriction
sites. The ﬁnal construct was conﬁrmed by DNA sequencing.
2.2. Gene expression
The 34-residue TLR3-TM was expressed as precipitate of the
reaction mixture (RM) in continuous exchange cell free (CF)
expression system [20,21]. S30 CF extract from Rosetta(DE3)pLysS
E. coli strain and T7 RNA polymerase were prepared by previously
described protocol [22]. Optimal reaction conditions were per-
formed using homemade reactors based on Mini-CECF-Reactor
previously described [22] and membranes with molecular weight
cut-off of 12.5 kDa. Preparative scale reactions (1–2 ml of RM)
were carried out in 50 ml tubes. The optimal FM:RM ratio was
12:1 and RM contained 100 mM HEPES/0.83 mM EDTA/KOH at
pH 8.0, 0.1 mg/mL folinic acid, 20 mM acetyl phosphate, 1.2 mM
ATP and 0.8 mM each of G/C/UTP, 2 mM 1,4-dithiothreitol, 0.05%
sodium azide, 2% PEG-8000, 20 mM magnesium acetate, 270 mM
potassium acetate, 60 mM creatine phosphate, 1 mM each of 20
amino acid or 0.25% of 20 amino-acid mix (CIL), 1 tablet/50 mL
complete protease inhibitor (Roche), 0.5 mg/mL E. coli tRNA
(Roche), 0.25 mg/mL creatine kinase from rabbit muscle (Roche),
0.05 mg/mL T7 RNA polymerase, 0.1 U/mkL Ribolock (Fermentas),
0.02 mkg/mkL plasmid DNA, and 30% S30 CF extract. All reagents
were provided by Sigma Aldrich, Germany unless otherwise
speciﬁed. Reactions were conducted overnight at 30 C and
150 rpm in an Innova 44R shaker (New Brunswick). 20-aminoacid
mixture of 13C/15N-labeled amino acids (CIL) was used to obtain
uniformly 13C/15N-labeled protein sample.
2.3. Protein puriﬁcation and solubilization
The protein precipitate was washed three times by buffer con-
taining 50 mM Tris pH 8.0 and 100 mM NaCl. RNAse A (Fermentas)
with ﬁnal concentration of 20 mkg/mkl was added into the buffer
at ﬁrst washing step. After each step protein was centrifuged for
10 min at 18000 g at room temperature and supernatant aliquots
were analyzed by 12,5% Tricine SDS–PAGE. The TLR3-TM was puri-
ﬁed by dissolving the washed precipitate in TFE/H2O mixture 2:1
and centrifuging for 10 min at 18000g. Dissolved protein was
added to DPC-d38 (CIL) powder at the initial lipid-to-protein ratio
(LPR) of 1:60. The concentration of TLR3-TM was assessed by the
protein absorption at 280 nm and by 1D NMR spectroscopy in
TFE/H2O (with respect to the internal reference peak of 1 mM
TSP). In order to achieve the incorporation of the peptide into the
micelle particles the resulting solution was diluted with water to
1:1 TFE/H2O ratio and lyophilized. Final NMR samples contained
0.9 mM of 13C/15N-TLR3-TM, 1.1 mM of 12C/14N-TLR3-TM,
120 mM of DPC-d38, 1 mM NaN3, and either 20 mM of sodium
acetate at pH 4.5 or 20 mM of phosphate buffer at pH 7.5.
2.4. NMR spectroscopy
All NMR experiments were run on 600 and 800 MHz Avance III
spectrometers equipped with cryogenic triple resonance probes
(Bruker Biospin, Germany) at 45 C. Free energies of dimerizationand oligomerization of TLR3-TM were measured through the pro-
cedure described in [23]. Populations of the oligomeric states were
determined from the intensities of 2D cross-peaks in BEST-TROSY
spectra [24] acquired with the relaxation delay of 0.8 s (selective
excitation T1 for amide protons was assessed as 0.15 s). Assign-
ment of chemical shifts was performed via the standard approach
[25] with use of triple resonance and NOE spectroscopy (NOESY)
3D NMR spectra. Non-uniform sampling in indirect dimensions
[26] and BEST [27] pulse sequences were used to detect the triple
resonance spectra. Constant-time evolution versions of NOESY-
13C-HSQC and HCCH-TOCSY experiments [28] were used to assign
signals frommethyl groups of TLR3-TM. Spin-echo difference spec-
tra were used to calculate vicinal J-couplings, depending on v1
dihedral angle [29,30]. 13C/15N-ﬁltered-13C-edited-NOESY-HSQC
[31] was recorded to directly detect intermolecular nuclear
overhauser effect (NOE) connectivities. Backbone torsion angles
restraints were obtained from the NMR chemical shifts in
TALOS + software [32]. Spatial structures of dimer and trimer were
calculated in CYANA 3.0 software [33], the obtained data were
visualized in MOLMOL [34]software.
3. Results
3.1. TLR3 TMD can form stable dimers and trimers
in dodecylphosphocholine (DPC) micelles
To study the homotypic interactions of TLR3 TMDs we have pro-
duced the peptide, corresponding to residues Asp698–Ile730 of the
full length receptor in the continuous exchange cell-free expres-
sion system. Assignment of NMR spectra acquired at lipid-to-pro-
tein ratio (LPR) 60 and pH 4.5 revealed that three sets of signals
can be detected for both amide protons and methyl groups of
TLR3-TM (Figs. 1A, B and S1). These sets are characterized by dif-
ferent correlation times for the rotational diffusion, indicating that
signals correspond to different oilgomeric states (Fig. 1C). This was
conﬁrmed by dodecylphosphocholine (DPC) titration experiments
– TLR3-TM appeared to form dimers and trimers, with standard
free energy of dimerization and trimerization being equal to
1.8 ± 0.1 and 2.0 ± 0.1 kcal/M (at 1 M of detergent standard
conditions) correspondingly (Fig. 1D and E). Therefore we can con-
clude that TLR3-TM forms dimers and trimers of moderate stability
in DPC micelles, TLR3-TM dimer is more stable than the dimers of
the TMDs of ErbB3 (0.5 kcal/M, [35]), ErbB4 (1.4 kcal/M, [36])
has comparable stability to FGFR3 (2.8 to 1.4 kcal/M, [37,38]),
but is much weaker than the dimers of glycophorin A (7 to
5 kcal/M [39,40]) or VEGFR2 (4.8 kcal/M, [23]) TMDs. Free ener-
gies of both dimerization and trimerization of the peptide were
found to be dependent on ambient pH and hydrophobic thickness
of the micelles, while the spatial structure of both dimers and tri-
mers was retained, according to NMR chemical shift changes
observed. Both types of helix–helix interactions were gradually
destabilized by the increase of the pH in the range 4.0–7.5 by
approximately 1 kcal/M (Fig. 1F). The pH dependence of the free
energies correlated with the titration curve of both His724 and
Glu726 sidechains of TLR3-TM (Fig. S2). On the other hand, addition
of hexadecylphosphocholine (FOS-16) to DPC caused the gradual
stabilization of both dimer and trimer up to 1 kcal/M at
FOS-16/DPC ratio equal to 0.4 (Fig. S3).
3.2. Structural properties of TLR3-TM dimers and trimers
Despite the severe complexity of NMR spectra, containing three
sets of signals, we managed to achieve almost 100% assignment of
NMR resonances. To reveal the structural parameters of transmem-
brane helix–helix interactions of TLR3-TM peptide we used the
Fig. 1. (A,B) Fragments of 1H,15N-TROSY spectra of the TLR3-TM, containing cross-peaks from N–H groups of residues Ile712 and Arg729. Spectra were acquired at pH 7.5 (A)
or 4.5 (B) and LPR 80. (C) Correlation times of rotational diffusion measured for N–H groups of selected residues of TLR3-TM, in monomeric (M, light gray), dimeric (D, dark
gray) and trimeric (T, black) states. Correlation times were calculated from cross-correlated NMR relaxation rates [46]. (D,E) Dependence of the apparent free energies of
dimerization on the concentration of detergent in empty micelles at pH 7.5, used to determine the free energies of the dimerization (D) and trimerization (E) of the TLR3-TM.
R is the universal gas constant, T is the temperature in K, [M], [D] and [T] are the concentration of monomers, dimers and trimers in solution, [Det]emic is the concentration of
detergent in empty micelles. For details see [23]. Data were approximated by the linear dependence, results of the approximation are shown. (F) pH dependence of the
standard free energies of dimerization (squares) and trimerization (rhomboids) of TLR3-TM.
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detection of intermolecular distances between 13C/15N-labeled
and unlabeled molecules (Fig. S7). Spectra were acquired at two
conditions: at pH 4.5 and LPR 60, when monomer/dimer/trimer
ratio was approximately 5/35/60 and at pH 7.5, LPR 120, when
the ratio was 60/30/10 (Fig. S3). We intentionally selected condi-
tions ﬁrst with maximal contents of the trimeric form and then
with maximal dimer/trimer ratio (to obtain the intermolecular
NOEs, corresponding to the dimeric state only). Analysis of NOE
contacts, observed in both spectra revealed that almost the whole
surface of the transmembrane (TM) helix is used either for the
dimerization or trimerization of the TLR3-TM (Fig. 2). Spectrum
recorded at pH 7.5 had relatively poor sensitivity (due to the low
concentration of dimeric species and extensive line broadening of
some cross-peaks) and only three interhelical contacts were
observed, between the sidechains of Thr710 and Leu714. These con-
tacts were then used to analyze the spectrum at pH 4.5, where the
intensities of peaks corresponding to the trimeric and dimeric
states were almost equal. The speciﬁed procedure allowed to
determine three distinct contact surfaces, the one involved in the
dimerization, including residues Phe706,Thr710, Leu714 and Phe718,
and two others used for the trimerization, including residues
Phe705, Asn709,Leu713 and Ile717 on one side of the TM helix and
Ile708, Ile712 and Phe716 on the other. These data were used to deter-
mine the spatial structures of both dimer and trimer (Fig. 2B and C,
Table S1). Unfortunately, NOE contacts to the sidechain of Asn13
were not observed, because its signals are extremely broad in
NMR spectra, therefore the hydrogen bonding pattern, accom-
plished by its polar amide group is not determined.
In addition to the contact surfaces our data reveal that the
secondary structure of the TLR3-TM is also affected by the dimer-
ization/trimerization. According to the secondary chemical shifts
of Ca nuclei, ﬁrst two turns of the TM-helix (Phe702–Asn709) are
destabilized for both monomeric and dimeric states in DPC, while
this part of the TMD is quite stable for the trimeric state. Thisphenomenon is not observed in DPC/FOS-16 mixed micelles. Addi-
tion of FOS-16 to DPC gradually changes Ca chemical shifts of
monomer until they almost exactly coincide with the chemical
shifts of the trimeric state observed in pure DPC solution
(Fig. S4). This observation is consistent with the fact that Asn709
is located on the trimerization interface. In monomeric and dimeric
states Asn709 sidechain may tend to form intramolecular hydrogen
bonds, which may cause the destabilization of the TM helix.
NMR chemical shifts and solved spatial structures were depos-
ited to BMRB and PDB with accession codes 19674, 2mk9 and
2mka.
4. Discussion
One of the reasons why we selected TLR3 for the current study
is the peculiar aminoacid sequence of its TMD. It includes unusu-
ally large quantity of aromatic residues – 6 Phe and Trp and a clus-
ter of relatively polar residues (Asn709Thr710Ser711) deep inside the
membrane. It is well-known that highly polar residues in TM heli-
ces can drive their association [41,42], and slightly polar residues,
such as Gly, Ser, Thr and Ala can mediate the TM helix–helix inter-
actions if they are put together in special motifs, such as GxxxG or
‘‘heptad-repeat’’ [43,44]. Aromatic sidechains also bear partial
charges and can engage in electrostatic interactions with other aro-
matic residues or polar sidechains, thus stabilizing the dimeriza-
tion/oligomerization of TM segments [45]. Nevertheless, none of
the putative helix interaction motifs are found in the sequence of
TLR3-TM. In this respect, it is rather interesting to analyze the
obtained structures. Here we report the ability of TLR3-TM to form
dimers and trimers with different surfaces for helix–helix interac-
tion. While the dimeric structure is stabilized by the van-der-
Waals interactions between bulky sidechains and stacking of aro-
matic rings of Phe706 and Phe718, the trimer formation is supported
by the contacts between polar sidechains of Asn709, stacking of
Phe705 and Phe716 aromatic rings and by the van-der-Waals
Fig. 2. (A) Molecular surface of TLR3-TM is painted with respect of observed NOE connectivities. Residues with detected intermolecular NOE’s in the dimer/trimer 1:2
mixture are divided into three surfaces: dimerization interface (green) and two surfaces employed for the trimerization (blue and green). Asn709 is shown in magenta. (B) Set
of 20 best calculated spatial structures of TLR3-TM dimer in ribbon representation. Sidechains of residues on the dimerization interface are shown by cylinders. (C)
Determined spatial structure of TLR3-TM in ribbon representation. Sidechains of residues on the dimerization interface are shown by cylinders. Phe705 and Phe716 sidechains
are shown in red, Asn709 sidechain is shown in magenta. (D) Asymmetric structure of the dimeric TMD of the TLR3, as predicted by the model of the full-length receptor [4].
Sidechain color code is the same as on panel (C). Places of steric hindrances are highlighted by black stars.
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Thr710 lies on the dimerization interface, but its sidechain does
not take part in any polar intermolecular contacts, instead forming
the intramolecular hydrogen bond with carbonyl group of Phe706
and another polar contact with the partial charge on its aromatic
ring. Therefore we can conclude that dimerization is driven mainly
by aromatic sidechains, while both aromatic residues and a polar
cluster play role in trimerization of TLR3-TM.
One may argue that the trimeric structure seems irrelevant
form the biological point, since the full-length TLR3 receptor never
forms trimers, but it uncovers the alternative way of helix–helix
interaction inside the dimeric TMD of the TLR3. In the symmetric
trimer each helix has two interaction surfaces and pairwise inter-
actions between a-helices is asymmetric. In this respect the spatial
structure of TLR3-TM trimer provides the information on the inter-
face of possible asymmetric dimerization of the TLR3 TMDs. This
interface is characterized by substantially higher free energy,
because no dimer, employing the found surfaces is observed, but
still it can be brought into effect in the full-length receptor.
The biological relevance of the contact surfaces determined for
the trimeric structure of TLR3-TM is supported by the model of the
full-length TLR3 receptor in the active state, constructed on
the basis of crystal structures of dimeric ECD and TIR domain in
the group of prof. Davies [4]. In this model TM helix has the same
disposition as was found in the present work – it starts at Phe702and ends at Phe725. Moreover, the structure of the dimeric TMD
is asymmetric and Asn709 is located on the dimerization interface
of one TM helix, while it is located aside from the contact area of
the second helix (Fig. 2D). Additionally, Ile712, Leu713, Ile715,
Phe716 and Ile717 are on the dimerization interface, which is similar
to determined in the present work trimeric structure. On the other
hand the structural parameters of helix–helix interaction in the
full-length model are different from the reported for the TLR3-
TM trimer. Transmembrane helices are slightly rotated and are
located closer in the full-length TLR3 model and the helix-helix
interface is extended towards the C-terminus of the TM domain.
However, we need to note, that the discussed model suffers from
the steric clashes in the TM region, and in reality the interaction
of TLR3 TMDs has to be slightly different and even may ﬁt to the
experimentally determined parameters of the reported trimeric
structure of the TLR3-TM. Therefore, we can state that the param-
eters of TM helix–helix interactions, observed in the trimeric struc-
ture of the TLR3-TM are close to the ones obtained in the full-size
model of the dimeric TLR3 receptor, and the observed trimeric
structure is likely to be relevant from the biological point. The
helix–helix interaction interface obtained in the present study for
the TLR3-TM dimer may also be employed by the full-size receptor
if the inactive dimeric state of the TLR3 is possible.
In summary, the structural and energetic parameters of helix–
helix interactions accomplished by TLR3 TMDs are reported. We
3806 K.S. Mineev et al. / FEBS Letters 588 (2014) 3802–3807show that TLR3-TM can formmoderately stable dimers and trimers
in detergent micelles, with stability of associates being dependent
on ambient pH and hydrophobic thickness of membrane mimetic.
NMR data revealed two possible surfaces that may be used for the
transmembrane helix–helix interaction. The obtained data pro-
vides an insight into the ‘‘blind spot’’ of TLR3 signaling – structure
of the transmembrane domain in the dimeric state, and can be
used in further mutagenesis studies, which are necessary to eluci-
date the role of transmembrane domains in the processes of signal
transduction by the TLR3 receptor.
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